Organ Preservation Market by Solution (UW/Custodiol HTK/Perfadex), Technique (Static Cold Storage/Hypothermic Machine Perfusion/ Normothermic Machine Perfusion), Organ Type (Kidneys/Liver/Lungs/Heart), Region - Global Forecast to 2024

臓器保存の世界市場予測:ソリューション別(UW/クストジオールHTK/パーファデックス)、技術別(静的冷蔵/低体温マシン灌流/正常体温灌流)、臓器種類別(腎臓/肝臓/肺/心臓)、地域別

◆タイトル:Organ Preservation Market by Solution (UW/Custodiol HTK/Perfadex), Technique (Static Cold Storage/Hypothermic Machine Perfusion/ Normothermic Machine Perfusion), Organ Type (Kidneys/Liver/Lungs/Heart), Region - Global Forecast to 2024
◆商品コード:MD 4464
◆調査・発行会社:MarketsandMarkets
◆発行日:2020年2月28日
◆ページ数:140
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD5,650 ⇒換算¥610,200見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥718,200見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥880,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

MarketsandMarkets社は臓器保存の世界市場が、2019年207百万ドルから2024年284百万ドルまで、年平均6.5%成長すると予測しています。本調査レポートでは、臓器保存の世界市場について調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場動向、ソリューション別(UW/クストジオール、HTK/パーファデックス)分析、技術別(静的冷蔵/低体温マシン灌流/正常体温灌流)分析、臓器種類別(腎臓/肝臓/肺/心臓)分析、地域別分析、競争状況、企業概要などを含め、次の構成でお届け致します。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場動向
・臓器保存の世界市場:ソリューション別(UW/クストジオール、HTK/パーファデックス)
・臓器保存の世界市場:技術別(静的冷蔵/低体温マシン灌流/正常体温灌流)
・臓器保存の世界市場:臓器種類別(腎臓/肝臓/肺/心臓)
・臓器保存の世界市場:地域別
・競争状況
・企業概要

“The organ preservation market is projected to grow at a CAGR of 6.5%.”
The global organ preservation market is projected to reach USD 284 million by 2024 from USD 207 million in 2019, at a CAGR of 6.5%. The growth of the organ preservation market is mainly driven by the increasing incidence of multi-organ failure, the growing geriatric population, the rising number of organ transplants and organ donors, and increasing initiatives to encourage organ donations. However, the high cost of organ transplantations and religious concerns in specific geographies are expected to limit market growth to a certain extent.

“The University of Wisconsin (UW) holds the market share in the solutions market.”
Based on the Solution, the segment is divided into UW, Custodial HTK, Perfadex and Other solutions (EuroCollins and Celsior). In 2019, the UW solution accounted for the highest share of 92.92 USD million in 2019. The UW solution is used for the flushing and storage of kidneys, liver, and pancreas. It was the first intracellular preservation medium, considered the gold standard for organ preservation. Paradox accounts for the most considerable CAGR in the forecast period of 2019-2024.

“Normothermic Machine Perfusion accounts for the highest CAGR in the forecast period.”
Normothermic machine perfusion marked the highest CAGR in the forecast period of 2019 to 2024. Normothermic perfusion is a technique that recreates the physiologic environment by maintaining average organ temperature and providing essential substrates for cellular metabolism, oxygenation, and nutrition. It is said to enhance the safety and efficacy of the organ and improve repair before transplantation. The normothermic technique is said to reduce the pro-inflammatory response in the liver and the risk of ischemic injuries while promoting graft regeneration. The possibility of long-term graft survival and reduced delayed graft functioning in organs of marginal quality (such as those from older donors) has made normothermic machine perfusion increasingly relevant.
Static cold storage and hypothermic machine perfusion are the other techniques involved in this segment.

“Kidneys holds the highest share in the segment by organ type.”
Kidneys accounts for a market share in the organ segment. Renal transplantation is considered the treatment of choice for patients with end-stage renal disease (ESRD) or kidney failure, diabetes, etc. are all cause for the growth of this segment. Other causes of ESRD in adult patients are polycystic kidney disease and glomerulonephritis. With the rising incidence of diabetes, the number of patients with ESRD or kidney failure is expected to increase, which will drive demand for kidney transplants. Moreover, improvements in graft survival and long-term graft function have made kidney transplantation a cost-effective alternative to dialysis. Major organs like Lungs, Liver, Kidney and Heart are a part of this segment.

“The Asia Pacific to witness the highest growth during the forecast period.”
Asia Pacific is expected to grow at the highest CAGR during the forecast period of 2019–2024. The major factors driving the growth of the Asia Pacific market include favorable government initiatives, increased awareness in people and increased organ donations. Intensified public education, mobilization, and advancements in organ transplant technologies have improved the donation rate in China. In India, Rapid improvements in the country’s healthcare infrastructure have supported market growth while encouraging medical tourism. The willingness to donate organs in Japan has led to the improvement in organ donation despite religious issues. Other countries have initiative reimbursement programs, paired organ donation scheme with other patients within the country and across countries, have improved the growth of this market drastically.

Break of primary participants was as mentioned below:
 By Company Type: Tier I: 50%, Tier II: 30%, Tier III: 20%
 By Designation: C-Level Executives: 37%, Directors: 29%, Others: 34%
 By Region: North America: 35%, Europe: 30%, Asia Pacific: 25%, RoW: 10%
XVIVO Perfusion AB (Sweden), Paragonix Technologies (US), Dr. Franz Kohler Chemie GMBH (Germany) are the leading players in the organ preservation market.

Research Coverage
This report studies the organ preservation market based on solution, technique, organ type, and region. The report also studies the different factors (such as drivers, restraints, and opportunities) affecting the market growth. It analyzes the opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets concerning their growth trends and forecasts the revenue of the market segments with respect to four central regions and respective countries.

Key Benefits of Buying the Report
This report focuses on various levels of analysis—industry trends, market shares of top players, and company profiles, which together form basic views and analyze the competitive landscape, emerging segments of the organ preservation market, and their drivers, restraints, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the organ preservation market.

【レポートの目次】

1 Introduction (Page No. – 17)
1.1 Objectives of the Study
1.2 Market Definition
1.2.1 Market Scope
1.2.2 Markets Covered
1.2.3 Years Considered for the Study
1.3 Currency
1.4 Limitations
1.5 Stakeholders

2 Research Methodology (Page No. – 21)
2.1 Research Data
2.2 Research Methodology Steps
2.2.1 Secondary Data
2.2.1.1 Secondary Sources
2.2.2 Primary Data
2.2.3 Primary Sources
2.2.4 Key Insights From Primary Sources
2.2.5 Market Size Estimation Methodology
2.2.6 Procedure-Based Market Estimation
2.2.7 Market Data Estimation and Triangulation
2.2.8 Assumptions of the Study

3 Executive Summary (Page No. – 31)

4 Premium Insights (Page No. – 34)
4.1 Organ Preservation Market Overview
4.2 Asia Pacific: Organ Preservation Market, By Technique (2019)
4.3 Organ Preservation Market, By Technique, 2019 vs 2024
4.4 Organ Preservation Market, By Organ Type, 2019 vs 2024
4.5 Geographic Snapshot of the Organ Preservation Market

5 Market Overview (Page No. – 38)
5.1 Introduction
5.2 Drivers
5.2.1 Rising Instances of Multiple Organ Failure and Growth in the Geriatric Population
5.2.2 Increasing Initiatives to Encourage Organ Donation
5.2.3 Rising Number of Organ Donors and Solid Organ Transplantation Procedures
5.3 Restraints
5.3.1 High Cost of Organ Transplantation
5.3.2 Religious Concerns and Misconceptions
5.4 Challenges
5.4.1 Significant Gap Between the Number of Organs Donated and Organs Required Annually
5.4.2 Development of Artificial Organs

6 Organ Preservation Market, By Solution (Page No. – 43)
6.1 Introduction
6.2 University of Wisconsin Solution
6.2.1 UW Solution Holds the Largest Share of the Organ Preservation Market
6.3 Custodiol HTK
6.3.1 Despite Low Cost and Easy Diffusion, Demand for Custodiol has Declined in Recent Years
6.4 Perfadex
6.4.1 North America Dominates the Market for Perfadex
6.5 Other Solutions

7 Organ Preservation Market, By Technique (Page No. – 52)
7.1 Introduction
7.2 Static Cold Storage
7.2.1 Static Cold Storage is the Conventional and Most-Adopted Method of Preserving Organs
7.3 Hypothermic Machine Perfusion
7.3.1 Enhanced Survival Rate and Preservation Quality have Fueled the Use of Hmp
7.4 Normothermic Machine Perfusion
7.4.1 Technological Developments and Advantages are Driving Market Growth

8 Organ Preservation Market, By Organ Type (Page No. – 61)
8.1 Introduction
8.2 Kidneys
8.2.1 Kidneys Hold the Largest Share of the Overall Market, By Organ Type
8.3 Liver
8.3.1 Rising Prevalence of Liver Disease and Failure is Driving Demand for Liver Transplantation
8.4 Lungs
8.4.1 Growth in Copd Incidence has Favored Demand for Preservation Techniques and Products
8.5 Heart
8.5.1 Advancements in Heart Preservation Techniques Will Support Market Growth
8.6 Other Organs

9 Organ Preservation Market, By Region (Page No. – 73)
9.1 Introduction
9.2 North America
9.2.1 US
9.2.1.1 Growing Cases of Organ Failure and Underlining Diseases to Drive the Demand for Organ Transplantation in the US
9.2.2 Canada
9.2.2.1 Canada has Registered Strong Growth in Overall Organ Donation Rates
9.3 Europe
9.3.1 France
9.3.1.1 France Holds the Largest Share of the Organ Preservation Market in Europe
9.3.2 Spain
9.3.2.1 Spain has Among the Highest Organ Donation Rates Globally
9.3.3 UK
9.3.3.1 Increasing Disease/Disorder Prevalence and Favorable Regulations Support the Growth of the UK Market
9.3.4 Italy
9.3.4.1 Growing Organ Donation and Transplant Rates Indicate Potential for Market Growth
9.3.5 Germany
9.3.5.1 Low Organ Donation and Transplant Rates Form A Major Concern for the German Market
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.1.1 Laws Favoring Organ Donation and Growing Awareness, Education, and Advancements Support Market Growth
9.4.2 India
9.4.2.1 Lack of Awareness is A Barrier to Market Growth
9.4.3 Japan
9.4.3.1 Religious Beliefs and Lack of Awareness have Affected Market Growth in Japan
9.4.4 Rest of Asia Pacific
9.5 Rest of the World

10 Competitive Landscape (Page No. – 106)
10.1 Introduction
10.2 Competitive Leadership Mapping (Overall Market)
10.2.1 Visionary Leaders
10.2.2 Innovators
10.2.3 Emerging Companies
10.2.4 Dynamic Differentiators
10.3 Competitive Scenario
10.3.1 Product Launches
10.3.2 Partnerships, Agreements, and Collaborations
10.3.3 Acquisitions

11 Company Profiles (Page No. – 111)
(Business Overview, Products Offered, Recent Developments, Competitive Analysis, MnM View)*
11.1 Paragonix Technologies
11.2 XVIVO Perfusion AB
11.3 Dr. Franz Köhler Chemie GmbH
11.4 Essential Pharmaceuticals
11.5 Transmedics
11.6 Organox Limited
11.7 21st Century Medicine
11.8 Shanghai Genext Medical Technology
11.9 Bridge to Life Limited
11.10 Waters Medical Systems
11.11 Preservation Solutions
11.12 Carnamedica
11.13 Transplant Biomedicals
11.14 Organ Assist
11.15 Institut Georges Lopez
11.16 Global Transplant Solutions
11.17 Avionord
11.18 Organ Preservation Solutions
11.19 Ebers
11.20 S.A.L.F.

*Business Overview, Products Offered, Recent Developments, Competitive Analysis, MnM View Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. – 134)
12.1 Discussion Guide
12.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
12.3 Available Customizations
12.4 Related Reports
12.5 Author Details

List of Tables (128 Tables)

Table 1 Growth in Geriatric Population (Above-60 Age Group), By Region, 2017 vs 2050 (Million)
Table 2 Number of Organ Donations, 2016–2018
Table 3 Organ Preservation Market, By Solution, 2017–2024 (USD Million)
Table 4 Organ Preservation Market for UW Solution, By Region, 2017–2024 (USD Million)
Table 5 North America: Organ Preservation Market for UW Solution, By Country, 2017–2024 (USD Million)
Table 6 Europe: Organ Preservation Market for UW Solution, By Country, 2017–2024 (USD Million)
Table 7 APAC: Organ Preservation Market for UW Solution, By Country, 2017–2024 (USD Million)
Table 8 Organ Preservation Market for Custodiol HTK, By Region, 2017–2024 (USD Million)
Table 9 North America: Organ Preservation Market for Custodiol HTK, By Country, 2017–2024 (USD Million)
Table 10 Europe: Organ Preservation Market for Custodiol HTK, By Country, 2017–2024 (USD Million)
Table 11 APAC: Organ Preservation Market for Custodiol HTK, By Country, 2017–2024 (USD Million)
Table 12 Organ Preservation Market for Perfadex, By Region, 2017–2024 (USD Million)
Table 13 North America: Organ Preservation Market for Perfadex, By Country, 2017–2024 (USD Million)
Table 14 Europe: Organ Preservation Market for Perfadex, By Country, 2017–2024 (USD Million)
Table 15 APAC: Organ Preservation Market for Perfadex, By Country, 2017–2024 (USD Million)
Table 16 Other Organ Preservation Solutions Market, By Region, 2017–2024 (USD Million)
Table 17 North America: Other Organ Preservation Solutions Market, By Country, 2017–2024 (USD Million)
Table 18 Europe: Other Organ Preservation Solutions Market, By Country, 2017–2024 (USD Million)
Table 19 APAC: Other Organ Preservation Solutions Market, By Country, 2017–2024 (USD Million)
Table 20 Organ Preservation Market, By Technique, 2017–2024 (USD Million)
Table 21 Static Cold Storage: Advantages & Disadvantages
Table 22 Static Cold Storage Market, By Region, 2017–2024 (USD Million)
Table 23 North America: Static Cold Storage Market, By Country, 2017–2024 (USD Million)
Table 24 Europe: Static Cold Storage Market, By Country, 2017–2024 (USD Million)
Table 25 APAC: Static Cold Storage Market, By Country, 2017–2024 (USD Million)
Table 26 Hypothermic Machine Perfusion: Advantages & Disadvantages
Table 27 Hypothermic Machine Perfusion Market, By Region, 2017–2024 (USD Million)
Table 28 North America: Hypothermic Machine Perfusion, By Country, 2017–2024 (USD Million)
Table 29 Europe: Hypothermic Machine Perfusion Market, By Country, 2017–2024 (USD Million)
Table 30 APAC: Hypothermic Machine Perfusion Market, By Country, 2017–2024 (USD Million)
Table 31 Normothermic Machine Perfusion: Advantages & Disadvantages
Table 32 Normothermic Machine Perfusion Market, By Region, 2017–2024 (USD Million)
Table 33 North America: Normothermic Machine Perfusion Market, By Country, 2017–2024 (USD Million)
Table 34 Europe: Normothermic Machine Perfusion Market, By Country, 2017–2024 (USD Million)
Table 35 APAC: Normothermic Machine Perfusion Market, By Country, 2017–2024 (USD Million)
Table 36 Organ Preservation Market, By Organ Type, 2017–2024 (USD Million)
Table 37 Number of Kidney Transplants in Major Countries, 2017 vs 2018
Table 38 Kidney Preservation Market, By Region, 2017–2024 (USD Million)
Table 39 North America: Kidney Preservation Market, By Country, 2017–2024 (USD Million)
Table 40 Europe: Kidney Preservation Market, By Country, 2017–2024 (USD Million)
Table 41 APAC: Kidney Preservation Market, By Country, 2017–2024 (USD Million)
Table 42 Number of Liver Transplants in Major Countries, 2017 vs 2018
Table 43 Liver Preservation Market, By Region, 2017–2024 (USD Million)
Table 44 North America: Liver Preservation Market, By Country, 2017–2024 (USD Million)
Table 45 Europe: Liver Preservation Market, By Country, 2017–2024 (USD Million)
Table 46 APAC: Liver Preservation Market, By Country, 2017–2024 (USD Million)
Table 47 Prevalence of Copd Cases, 2010 vs 2016
Table 48 Number of Lung Transplants in Major Countries, 2017 vs 2018
Table 49 Lung Preservation Market, By Region, 2017–2024 (USD Million)
Table 50 North America: Lung Preservation Market, By Country, 2017–2024 (USD Million)
Table 51 Europe: Lung Preservation Market, By Country, 2017–2024 (USD Million)
Table 52 APAC: Lung Preservation Market, By Country, 2017–2024 (USD Million)
Table 53 Number of Heart Transplants in Major Countries, 2017 vs 2018
Table 54 Heart Preservation Market, By Region, 2017–2024 (USD Million)
Table 55 North America: Heart Preservation Market, By Country, 2017–2024 (USD Million)
Table 56 Europe: Heart Preservation Market, By Country, 2017–2024 (USD Million)
Table 57 APAC: Heart Preservation Market, By Country, 2017–2024 (USD Million)
Table 58 Other Organ Preservation Market, By Region, 2017–2024 (USD Million)
Table 59 North America: Other Organ Preservation Market, By Country, 2017–2024 (USD Million)
Table 60 Europe: Other Organ Preservation Market, By Country, 2017–2024 (USD Million)
Table 61 APAC: Other Organ Preservation Market, By Country, 2017–2024 (USD Million)
Table 62 Organ Preservation Market, By Region, 2017–2024 (USD Million)
Table 63 North America: Organ Preservation Market, By Country, 2017–2024 (USD Million)
Table 64 North America: Organ Preservation Market, By Technique, 2017–2024 (USD Million)
Table 65 North America: Organ Preservation Market, By Solution, 2017–2024 (USD Million)
Table 66 North America: Organ Preservation Market, By Organ Type, 2017–2024 (USD Million)
Table 67 Number of Organ Transplants in the US, 2016–2018
Table 68 Waiting List for Organ Transplants, as of January 2020
Table 69 US: Organ Preservation Market, By Technique, 2017–2024 (USD Million)
Table 70 US: Organ Preservation Market, By Solution, 2017–2024 (USD Million)
Table 71 US: Organ Preservation Market, By Organ Type, 2017–2024 (USD Million)
Table 72 Number of Organ Transplants in Canada, 2016–2018
Table 73 Canada: Organ Preservation Market, By Technique, 2017–2024 (USD Million)
Table 74 Canada: Organ Preservation Market, By Solution, 2017–2024 (USD Million)
Table 75 Canada: Organ Preservation Market, By Organ Type, 2017–2024 (USD Million)
Table 76 Europe: Organ Preservation Market, By Country, 2017–2024 (USD Million)
Table 77 Europe: Organ Preservation Market, By Technique, 2017–2024 (USD Million)
Table 78 Europe: Organ Preservation Market, By Solution, 2017–2024 (USD Million)
Table 79 Europe: Organ Preservation Market, By Organ Type, 2017–2024 (USD Million)
Table 80 Number of Organ Transplants in France, 2016–2018
Table 81 France: Organ Preservation Market, By Technique, 2017–2024 (USD Million)
Table 82 France: Organ Preservation Market, By Solution, 2017–2024 (USD Million)
Table 83 France: Organ Preservation Market, By Organ Type, 2017–2024 (USD Million)
Table 84 Number of Organ Transplants in Spain, 2016–2018
Table 85 Spain: Organ Preservation Market, By Technique, 2017–2024 (USD Million)
Table 86 Spain: Organ Preservation Market, By Solution, 2017–2024 (USD Million)
Table 87 Spain: Organ Preservation Market, By Organ Type, 2017–2024 (USD Million)
Table 88 Number of Organ Transplants in the UK, 2016–2018
Table 89 UK: Organ Preservation Market, By Technique, 2017–2024 (USD Million)
Table 90 UK: Organ Preservation Market, By Solution, 2017–2024 (USD Million)
Table 91 UK: Organ Preservation Market, By Organ Type, 2017–2024 (USD Million)
Table 92 Number of Organ Transplants in Italy, 2016–2018
Table 93 Italy: Organ Preservation Market, By Technique, 2017–2024 (USD Million)
Table 94 Italy: Organ Preservation Market, By Solution, 2017–2024 (USD Million)
Table 95 Italy: Organ Preservation Market, By Organ Type, 2017–2024 (USD Million)
Table 96 Number of Organ Transplants in Germany, 2016–2018
Table 97 Germany: Organ Preservation Market, By Technique, 2017–2024 (USD Million)
Table 98 Germany: Organ Preservation Market, By Solution, 2017–2024 (USD Million)
Table 99 Germany: Organ Preservation Market, By Organ Type, 2017–2024 (USD Million)
Table 100 RoE: Organ Preservation Market, By Technique, 2017–2024 (USD Million)
Table 101 RoE: Organ Preservation Market, By Solution, 2017–2024 (USD Million)
Table 102 RoE: Organ Preservation Market, By Organ Type, 2017–2024 (USD Million)
Table 103 APAC: Organ Preservation Market, By Country, 2017–2024 (USD Million)
Table 104 APAC: Organ Preservation Market, By Technique, 2017–2024 (USD Million)
Table 105 APAC: Organ Preservation Market, By Solution, 2017–2024 (USD Million)
Table 106 APAC: Organ Preservation Market, By Organ Type, 2017–2024 (USD Million)
Table 107 China: Organ Preservation Market, By Technique, 2017–2024 (USD Million)
Table 108 China: Organ Preservation Market, By Solution, 2017–2024 (USD Million)
Table 109 China: Organ Preservation Market, By Organ Type, 2017–2024 (USD Million)
Table 110 Centers Performing Organ Transplant and Retrieval Procedures in India
Table 111 Number of Organ Transplants in India, 2016–2018
Table 112 India: Organ Preservation Market, By Technique, 2017–2024 (USD Million)
Table 113 India: Organ Preservation Market, By Solution, 2017–2024 (USD Million)
Table 114 India: Organ Preservation Market, By Organ Type, 2017–2024 (USD Million)
Table 115 Japan: Organ Preservation Market, By Technique, 2017–2024 (USD Million)
Table 116 Japan: Organ Preservation Market, By Solution, 2017–2024 (USD Million)
Table 117 Japan: Organ Preservation Market, By Organ Type, 2017–2024 (USD Million)
Table 118 RoAPAC: Organ Preservation Market, By Technique, 2017–2024 (USD Million)
Table 119 RoAPAC: Organ Preservation Market, By Solution, 2017–2024 (USD Million)
Table 120 RoAPAC: Organ Preservation Market, By Organ Type, 2017–2024 (USD Million)
Table 121 Number of Organ Transplants in Saudi Arabia, 2016–2018
Table 122 Number of Organ Transplants in Israel, 2016–2018
Table 123 RoW: Organ Preservation Market, By Technique, 2017–2024 (USD Million)
Table 124 RoW: Organ Preservation Market, By Solution, 2017–2024 (USD Million)
Table 125 RoW: Organ Preservation Market, By Organ Type, 2017–2024 (USD Million)
Table 126 Product Launches (2016–2019)
Table 127 Partnerships, Agreements, and Collaborations (2016–2019)
Table 128 Acquisitions (2016–2019)

List of Figures (21 Figures)

Figure 1 Research Methodology: Organ Preservation Market
Figure 2 Research Design
Figure 3 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 4 Research Methodology: Hypothesis Building
Figure 5 Data Triangulation Methodology
Figure 6 Organ Preservation Market, By Solution, 2019 vs 2024
Figure 7 Organ Preservation Market, By Technique, 2019
Figure 8 Organ Preservation Market, By Organ Type, 2019 vs 2024 (USD Million)
Figure 9 Geographical Snapshot of the Organ Preservation Market
Figure 10 Increasing Incidence of Multi-Organ Failure Will Drive Market Growth
Figure 11 Static Cold Storage Accounts for the Largest Share of the Asia Pacific Organ Preservation Market
Figure 12 Static Cold Storage Technique to Dominate the Organ Preservation Market in 2024
Figure 13 Kidneys to Account for the Largest Market Share in 2019
Figure 14 APAC to Register the Highest CAGR in the Forecast Period
Figure 15 Organ Preservation Market: Drivers, Restraints, & Challenges
Figure 16 North America Commands the Largest Share of the Organ Preservation Market
Figure 17 North America: Organ Preservation Market Snapshot
Figure 18 Asia Pacific: Organ Preservation Market Snapshot
Figure 19 Key Developments in the Organ Preservation Market, 2017–2019
Figure 20 Organ Preservation Market: Competitive Leadership Mapping, 2018
Figure 21 XVIVO Perfusion AB: Company Snapshot (2018)



★調査レポート[臓器保存の世界市場予測:ソリューション別(UW/クストジオールHTK/パーファデックス)、技術別(静的冷蔵/低体温マシン灌流/正常体温灌流)、臓器種類別(腎臓/肝臓/肺/心臓)、地域別] ( Organ Preservation Market by Solution (UW/Custodiol HTK/Perfadex), Technique (Static Cold Storage/Hypothermic Machine Perfusion/ Normothermic Machine Perfusion), Organ Type (Kidneys/Liver/Lungs/Heart), Region - Global Forecast to 2024 / MD 4464) 販売に関する免責事項
[臓器保存の世界市場予測:ソリューション別(UW/クストジオールHTK/パーファデックス)、技術別(静的冷蔵/低体温マシン灌流/正常体温灌流)、臓器種類別(腎臓/肝臓/肺/心臓)、地域別] ( Organ Preservation Market by Solution (UW/Custodiol HTK/Perfadex), Technique (Static Cold Storage/Hypothermic Machine Perfusion/ Normothermic Machine Perfusion), Organ Type (Kidneys/Liver/Lungs/Heart), Region - Global Forecast to 2024 / MD 4464) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆